Senturk Hakan, Kabay Sahin, Bayramoglu Gokhan, Ozden Hilmi, Yaylak Faik, Yucel Mehmet, Olgun Esra Gurlek, Kutlu Ali
Faculty of Science, Department of Biology, Osmangazi University, Eskisehir, Turkey.
World J Urol. 2008 Aug;26(4):401-7. doi: 10.1007/s00345-008-0256-1. Epub 2008 Apr 12.
Renal ischemia/reperfusion (I/R) injury is associated with increased mortality and morbidity rates due to acute renal failure (ARF). Oxidative stress induced with renal I/R injury directly affects glomerular and tubular epithelium through reactive oxygen species. Several studies have been directed to the treatment of renal I/R injury. The aim of this study was to test the attenuation with silymarin (SM) treatment of renal I/R injury-induced morphological changes in the rat kidney.
A total of 32 adult male Sprague-Dawley rats were evaluated in four groups. Group I (sham), Group II (renal I/R), Group III (renal I/R injury + SM 50 mg per kg) and Group IV (renal I/R injury + SM 100 mg per kg) were designed to evaluate the dose-dependent effects of SM on the morphological changes of renal I/R injury. Renal I/R injury were induced with left renal pedicle occlusion for 45 min followed with reperfusion for 6 h under anesthesia. After induction of I/R injury, left nephrectomies were performed for histopathological examinations.
After renal I/R injury, significant tubular dilatation, tubular vacuolization, pelvic inflammation, interstitial inflammation, perirenal adipose infiltration, tubular necrosis and glomerular necrosis (cortical necrosis) were observed. However, even with low dose SM in Group III (50 mg per kg SM), histopathological changes due to I/R injury were prevented.
The results of this study have demonstrated that SM significantly prevents renal I/R injury-induced renal tubular changes in the rat. SM in 50 mg/kg was observed to be sufficient to significantly prevent renal tubular necrosis. Further, to our literature knowledge, this is the first specific study to demonstrate the preventive effect of SM on renal I/R injury.
肾缺血/再灌注(I/R)损伤与急性肾衰竭(ARF)导致的死亡率和发病率增加相关。肾I/R损伤诱导的氧化应激通过活性氧直接影响肾小球和肾小管上皮。已有多项研究致力于肾I/R损伤的治疗。本研究的目的是测试水飞蓟宾(SM)治疗对大鼠肾I/R损伤诱导的形态学变化的减轻作用。
总共32只成年雄性Sprague-Dawley大鼠被分为四组进行评估。第一组(假手术组)、第二组(肾I/R组)、第三组(肾I/R损伤 + 50 mg/kg SM)和第四组(肾I/R损伤 + 100 mg/kg SM),旨在评估SM对肾I/R损伤形态学变化的剂量依赖性影响。在麻醉下通过左肾蒂闭塞45分钟,然后再灌注6小时诱导肾I/R损伤。诱导I/R损伤后,进行左肾切除术以进行组织病理学检查。
肾I/R损伤后,观察到明显的肾小管扩张、肾小管空泡化、肾盂炎症、间质炎症、肾周脂肪浸润、肾小管坏死和肾小球坏死(皮质坏死)。然而,即使在第三组(50 mg/kg SM)中使用低剂量的SM,也能预防I/R损伤引起的组织病理学变化。
本研究结果表明,SM可显著预防大鼠肾I/R损伤诱导的肾小管变化。观察到50 mg/kg的SM足以显著预防肾小管坏死。此外,据我们所知,这是第一项证明SM对肾I/R损伤具有预防作用的具体研究。